Collegium outlines $805M-$825M 2026 product revenue outlook while planning to close $650M AZSTARYS deal in Q2
Collegium Pharmaceutical, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $31.78
-14% in 7d after detection
Post-detection moves
1h
—
1d
-3.9%
3d
-9.3%
7d
-14%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS